Navigation Links
Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families
Date:10/10/2007

NEW YORK, Oct. 10 /PRNewswire/ -- On Oct. 23rd, the fashion and corporate worlds will join Hazelden in honoring Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue, at "Fresh Start," Hazelden's New York Awards Dinner to Benefit programs for Youth and Families, which will take place at The Pierre Grand Ballroom. Bill Moyers will host the evening, which will feature a performance by Judy Collins. The event, which is sold out, is expected to raise more than $1 million, with proceeds going to help Hazelden expand its capacity on the East Coast to treat more youth addicted to alcohol and other drugs, help them find recovery, and give them a fresh start.

Sadove will receive the William D. Hassett Distinguished Leadership Award for his philanthropy and community leadership in supporting addiction treatment and prevention programs.

"We are honored to recognize and celebrate Steve Sadove, who has been steadfast in his support of Hazelden and those struggling with the disease of addiction," said Ellen Breyer, Hazelden President and CEO. "Steve is not only an extraordinary business leader, he is a compassionate individual dedicated to helping others, and we are fortunate that he is part of the Hazelden family."

Sue and Jim Cusack, founders of Veritas Villa, will accept Hazelden's Distinguished Service Award, which recognizes those who have encouraged others to seek treatment and for supporting the community in addressing and handling addiction as a controllable disease.

The event's Honorary Chair is the Honorable Paul A. Volcker and the Dinner Chair for the evening is Ronald L. Frasch, President and Chief Merchandising Officer, Saks Fifth Avenue. Co-Chairs for the event are Peter R. Dolan, Marvin H. Koslow, Lawrence Kudlow, Jack Leslie and Thomas J. Schwarz. Patron Committee Co-Chairs are Margaret B. Hassett and Judith Davidson Moyers.

The Fashion Committee for the event includes: Robert Ackerman, Ermenegildo Zegna; Mark Badgley, Badgl
'/>"/>

SOURCE The Hazelden Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. US Academy honors 15 for major contributions to science
2. American Cancer Society Honors Exemplary Cancer Caregivers
3. Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan
4. Fifth US Patient Receives Artificial Heart
5. Fifth case of bird flu in China confirmed
6. Czech Republic struck by fifth bird flu incident
7. Diabetes Labeled As Worlds Fifth Killer Disease
8. One- Fifths of Lung Cancer Patients are Non-smoking Women: Study
9. One-fifth of Obese Women Undergo Caesarean Due to Uterus Failure
10. Boffins Identify Fifth Gene Behind Joubert Syndrome
11. Bobby Robson Diagnosed With Cancer for Fifth Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...rst Medication Indicated for Maintenance Treatment...all/ -- Eli Lilly and Company,(NYSE: LLY ) announ...inistration (FDA) has approved Strattera(R) (atomo...-Deficit/Hyperactivity Disorder (ADHD) in,children...hrine reuptake,inhibitor, is the first FDA-approve...
(Date:5/9/2008)...NGELES, May 9 /PRNewswire/ -- Los Angeles based Op...n Asia to assess the needs of what is now,an estim...ne which,destroyed or devastated wide swaths of My...ormerly the capital Rangoon) and throughout its va... of over 120 miles per hour and,struck communities...
(Date:5/9/2008)...tion for Iraq and Afghanistan Veterans Gather in V...eterans Service Organizations,, CHANTILLY, Va....raq,enters its fifth year and the U.S. death toll ...he 30,000 mark, a diverse coalition of military,an...have organized to help,bereaved families and wound...
(Date:5/9/2008)...ual demands reap mental benefits regardless of age...ay 9 (HealthDay News) -- Having an intellectually ... result in better cognitive abilities during retir... or age, a Duke University Medical Center study su...work longer than previous generations, so we sough...
Breaking Medicine News(10 mins):Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 3Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 5Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 6Health News:Los Angeles Based Operation USA Appeals for Funds to Aid in Myanmar (Burmese) Cyclone Disaster (Updated) 2Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 2Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 3Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 4Health News:Demanding Jobs May Pay Cognitive Dividends in Retirement 2
...t was found that transferring growth factor genes ...ance.// In angina, the blood supply to the heart i...the body tries to compensate by growing new blood ...some unknown reason, this process, known as angiog...
...85, is a leading developer of an oxygen-carrying b...y blood substitute undergoing clinical trials that...sidered a substitute for acute blood loss in traum...ss used to manufacture the blood substitute, essen...
...eating in certain susceptible individuals. Researc... at the factors that make some people// susceptibl...nificant symptom. In a new study, they find that t...h lack of sunshine encouraging more eating. This ...
...ersity at Buffalo School of Dental Medicine ,they ...ray// may serve as an accurate early-warning syste...e study was ushered in a population with a high in...study move us closer to the use of panoramic denta...
Other Medicine News:
(Date:5/8/2008)... BOSTON, May 8 /- The Cancer Res... the nation,s top cancer centers, is asking,303 mi...r by donating $1 to,cancer research efforts this M...dubbed the "Infinite Power of One(TM)" has two key...atters into their own hands by,joining together to...
(Date:5/8/2008)... TAMPA, Fla., May 8 /-...harmaceutical company, today announced results fro...(morphine sulfate,extended-release with sequestere...clinically relevant features addressing abuse liab...ofile. The Phase I and II,studies, presented at th...
(Date:5/8/2008)... NEW HAVEN, Conn., May 8 /PRNewswire-FirstCal...today announced the start of an investigator-spons...cer agent Cloretazine(R),(VNP40101M) in combinatio...sly untreated acute myelogenous leukemia (AML) and...ial is being conducted under the,direction of Elle...
(Date:5/8/2008)... - Memorial Sloan-Kettering Cancer Center Inves...CA-Negative Ovarian Cancer Patients -, BRISBANE, ... today,announced the expansion of Phase 2 clinical...ovarian cancer. This is the third major clinical t...t 6 months, expanding on,on-going trials in breast...
Breaking Medicine Technology:World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Novel Cooling Therapy May Have Aided Injured Football Player 1209 1Novel Cooling Therapy May Have Aided Injured Football Player 1209 2Novel Cooling Therapy May Have Aided Injured Football Player 1209 3Novel Cooling Therapy May Have Aided Injured Football Player 1209 4Leaderless movement proves illusive 380 1Leaderless movement proves illusive 380 2Joint Juice Launches New Ready to Drink Glucosamine 26 Vitamin Enhanced Dietary Supplement Water Nationwide 1207 1Joint Juice Launches New Ready to Drink Glucosamine 26 Vitamin Enhanced Dietary Supplement Water Nationwide 1207 2Frances Decker Named Mid Atlantic Region Sales Executive for AllOne Health Management Solutions 1205 1Frances Decker Named Mid Atlantic Region Sales Executive for AllOne Health Management Solutions 1205 2
... significant additional protection against,infecti...cervical,cancer candidate vaccine, PHILADELPHIA, J...m an interim analysis of a Phase III study show th...r candidate vaccine,provides up to 100 percent pr...sed by the most common types of human papillomavir...
...Synagis Decreases Incidence of Recurrent Wheeze by...Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbot...tudy, published in the July issue of Journal of,Pe...palivizumab),may reduce recurrent wheezing in prem...study showed that premature infants without,chroni...
Other Medicine Technology:Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
...CHEM EZ is a small bench top chemistry analyzer th...erformed on reagent strips with results available ...sts per hour. The instrument accepts whole blood s...ipe of a magnetic card. At the conclusion of testi...
Veriteq's Refrigerator and Freezer Monitoring System is a data logger monitoring system for refrigerators and freezers that is easy to install. Using a building's existing ethernet network, Veriteq's
The ThermaViewer™ is constructed and engineered for use in laboratories, hospitals, and commercial kitchens to monitor and document freezer and refrigerator temperatures where inventory is store
This requiring no water for use, it provides convenient, long-lasting hand hygiene to physically clean hands when routine hand washing is either not an option or is not convenient. Hibistat allows yo
Medicine Products: